Journal profile · Biochemistry & Molecular Biology
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
ISSN 0167-4889 · eISSN 1879-2596 · Elsevier · NETHERLANDS · Monthly · Founded 1947
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH: CAS Zone 3 · Biology (2025 upgraded edition); impact factor 4.32; hybrid open access; APC about USD 3,930; median 138 days to acceptance (106 articles, last 24 months); community-reported acceptance: about 33.75%; 189 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH is published by Elsevier and is in Zone 3 of Biology in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Protein Kinase Regulation and GTPase Signaling, Mitochondrial Function and Pathology and Ion channel regulation and function, together about 18% of its articles. Its main subfields are Molecular Biology. (generated from OpenAlex topic counts and CAS ranking data)
BBA Molecular Cell Research focuses on understanding the mechanisms of cellular processes at the molecular level. These include aspects of cellular signaling, signal transduction, cell cycle, apoptosis, intracellular trafficking, secretory and endocytic pathways, biogenesis of cell organelles, cytoskeletal structures, cellular interactions, cell/tissue differentiation and cellular enzymology. Also included are studies at the interface between Cell Biology and Biophysics which apply for example novel imaging methods for characterizing cellular processes.
Source: LetPub
Research area (LetPub): Biochemistry & Molecular Biology
Main research topics OpenAlex counts of recent articles; shares are approximate
- Protein Kinase Regulation and GTPase SignalingBiochemistry, Genetics and Molecular Biology6.4%
- Mitochondrial Function and PathologyBiochemistry, Genetics and Molecular Biology6%
- Ion channel regulation and functionBiochemistry, Genetics and Molecular Biology5.6%
- Cellular transport and secretionBiochemistry, Genetics and Molecular Biology5%
- Diverse Scientific and Economic StudiesEconomics, Econometrics and Finance4.9%
- Pancreatic function and diabetesMedicine4.8%
- Receptor Mechanisms and SignalingBiochemistry, Genetics and Molecular Biology4.8%
- Human auditory perception and evaluationEngineering4.8%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Biology Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Biology | Zone 3 |
| Minor | Biochemistry & Molecular Biology | Zone 3 |
| Minor | Cell Biology | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Biology Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Biology | Zone 3 |
| Minor | Biochemistry & Molecular Biology | Zone 3 |
| Minor | Cell Biology | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Biology Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Biology | Zone 2 |
| Minor | Biochemistry & Molecular Biology | Zone 3 |
| Minor | Cell Biology | Zone 3 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 4.32LetPub ·
- CiteScore 2026-06
- 7.5LetPub ·
- SJR 2026-06
- 1.5LetPub ·
- SNIP 2026-06
- 1LetPub ·
- h-index
- 155LetPub ·
- h-index
- 251OpenAlex ·
- i10-index
- 6,815OpenAlex ·
- 2-year mean citedness
- 4.23OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 32.82%LetPub ·
Volume
- Articles per year
- 172LetPub ·
Articles by year OpenAlex count · 9,480 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 118 | 54 | 53 |
| 2025 | 189 | 104 | 559 |
| 2024 | 199 | 199 | 1,530 |
| 2023 | 183 | 181 | 2,378 |
| 2022 | 146 | 146 | 2,758 |
| 2021 | 177 | 177 | 3,849 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
138 daysMedian, submission to acceptance · P25–P75 109 days – 201 days
- Acceptance to online
- median 2 days (106 articles)
- Submission to online
- median 140 days
- Sample
- 106 articles with submission and acceptance dates (377 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 2.5 monthsLetPub ·
- Average acceptance (community reports)
- 33.75%LetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 3,930 / EUR 3,680 / GBP 3,150 / JPY 487,440 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Elsevier
- Country or region
- NETHERLANDS
- Language
- Dutch
- Frequency
- Monthly
- Founded
- 1947
- ISSN
- 0167-4889
- Electronic ISSN
- 1879-2596
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
FAQ
Frequently asked questions about BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
What CAS zone is BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH in?
In the 2025 upgraded edition of the CAS Journal Ranking, BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH is in Zone 3 of Biology, and in Zone 3 of the minor category Biochemistry & Molecular Biology / Cell Biology. In the 2026 Xinrui edition it is in Zone 3 of Biology. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH?
The latest impact factor listed by LetPub is 4.32; CiteScore 7.5, h-index 251.
How long does peer review take at BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH?
Based on the dates recorded on 106 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 138 days (interquartile range 109–201 days); authors report an average review time of about 2.5 months; the community-reported acceptance is “about 33.75%”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH?
According to LetPub and DOAJ records, BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH is indexed in SCIE and Scopus.
Is BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH open access, and what is the APC?
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH is a hybrid journal. For open-access publication: APC about USD 3,930.
Sources and updates
The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-30). Last updated: .